Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

CSE:BRAX - Post Discussion

Braxia Scientific Corp > so that was the big announcement....
View:
Post by cautiousguy on Aug 28, 2020 4:01pm

so that was the big announcement....

So the big announcement has been that the CEO is administering a Johnson & Johnson product that does not appear to be related to SHRM or psilocybin research. The lesser announcement is that the paper work is still not complete or acceptable enough to lift the hold.  Moreover, there is no indication of how long before this ongoing -dare I say- incompetence will be rectified.

  Last time I looked, Twitter still has the top stories from a couple of months age posing as exciting company updates. 

All right now somebody post about my "bashing" and tell others that this is just a blip -not even a burp- and really it's the previous bunch that is to blame.  We'll all be laughing about this by Christmas or Festivus or ....
Comment by OriginalG on Aug 28, 2020 4:16pm
you're right, its related to pcp and is approved, unlike psilocybin which is approved for research only. i find it interesting that you continue to whine about the new execs yet ignore the previous execs who were responsible for the screw up. did you get stock from the pos shells that were valued at millions for no good reason?
Comment by cautiousguy on Aug 28, 2020 5:22pm
Yeah, Gee, I made a killing off the early shares with my confederates.  Now, being indescribably wealth, and with nothing better to do, I'm just posting here to throw you off the scent.  But it turns out you are too clever for me.  You're right about the new board, they have been flawless for the past few months.  Things have never run better.  One day they will ...more  
Comment by OriginalG on Aug 28, 2020 8:26pm
They issued almost as many shares for 3 nothing companies as they did for Altmed and you only bash the Altmed transaction and people. Either you have an axe to grind or your misguided - dotting i's crossing t's was a failure of their predecessors.
Comment by cautiousguy on Aug 28, 2020 8:34pm
So this most recent failure to complete the ALTMED BAR is the fault of the previous board?  Is that your position?
Comment by OriginalG on Aug 29, 2020 11:52am
Since you asked, yes! The sedar filings lays out who's responsible for what. Since the ceo was Altmed the Bar was previous execs responsibility as were the 3 bs purchases prior. But you essentially proved my point - either your misguided or you have a bone to pick. Why dont you hold previous management responsible?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities